MoneyWorks4Me

Alkem Laboratories informs about quarterly statement of investor complaint

19 Jan 2016 Evaluate

Alkem Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1792.80
Dr. Reddys Labs. 1198.10
Cipla 1326.90
Lupin 2010.95
Zydus Lifesciences 1135.50
View more..